Analyst Ratings For Biodel (NASDAQ:ALBO)
Today, Needham & Company LLC initiated coverage on Biodel (NASDAQ:ALBO) with a Buy with a price target of $35.00.
There are 4 buy ratings on the stock.
The current consensus rating on Biodel (NASDAQ:ALBO) is Buy (Score: 3.00) with a consensus target price of $35.00 per share, a potential 30.74% upside.
Some recent analyst ratings include
- 7/18/2017-Needham & Company LLC initiated coverage with a Buy rating.
- 6/30/2017-Wedbush initiated coverage with a Outperform rating.
- 2/16/2017-Ladenburg Thalmann Financial Services initiated coverage with a Buy rating.
- 1/25/2017-William Blair initiated coverage with a Outperform rating.
Recent Insider Trading Activity For Biodel (NASDAQ:ALBO)
Biodel (NASDAQ:ALBO) has insider ownership of 22.30% and institutional ownership of 12.35%.
- On 12/20/2013 Brian Jg Pereira, Director, sold 4,734 with an average share price of $2.26 per share and the total transaction amounting to $10,698.84. View SEC Filing
Recent Trading Activity for Biodel (NASDAQ:ALBO)
Shares of Biodel closed the previous trading session at 26.47 down -0.30 -1.12% with 31,084 shares trading hands.